跳至主要内容
临床试验/IRCT20090117001556N146
IRCT20090117001556N146招募中2 期

Sulforaphane as an adjuvant therapy in children with attention-deficit/hyperactivity disorder (ADHD): A randomized, double-blind, placebo-controlled clinical trial

Tehran University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6 years 至 11 years(—)
性别
All

入选标准

  • Age between 6-11 years
  • Diagnosis of ADHD based on DSM5

排除标准

  • Age range outside 6-11 years
  • Diagnosis of a serious disease, or disease requiring surgery, or neurological diseases
  • Diagnosis of a psychiatric disorder and taking neuropsychiatric drugs, except for ADD
  • History of treatment with sulforaphane in the last three months
  • History of treatment with neuroleptic medication in the last six months
  • Weight less than 13.5 kg
  • Mental retardation
  • A systolic blood pressure greater than 125 or a resting heart rate less than 60 or greater than 115
  • History of allergy to sulforaphane or methylphenidate

研究者

相似试验